Bipolar II Disorder
Neurology
3
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
1
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Alliance PharmaceuticalsUK - Wiltshire
1 program1
Interpersonal and Social Rhythm TherapyPhase 2/31 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AstraZenecaQuetiapine/Seroquel
Alliance PharmaceuticalsInterpersonal and Social Rhythm Therapy
GH ResearchGH001
Clinical Trials (3)
Total enrollment: 80 patients across 3 trials
Seroquel in the Treatment of Dysphoric Hypomania in Bipolar II
Start: Aug 2008Est. completion: Aug 201155 patients
Phase 4Completed
Psychotherapy for Bipolar II Depression, Pilot Study, Phase II
Start: Dec 2006Est. completion: Sep 201025 patients
Phase 2/3Completed
Phase 2 Clinical Trial of GH001 in Bipolar II Disorder
Start: Apr 2023Est. completion: Dec 2024
Phase 2Terminated
Related Jobs in Neurology
Director, Distribution & Services
Xenon Pharmaceuticals
Remote
8h ago
Senior Medical Science Liaison (NYC Tri-State)
Xenon Pharmaceuticals
Remote
8h ago
$208K - $234K/yr
Director of Medical Affairs
CoMind
Miami, FL
9h ago
Director of Finance
CoMind
London, UK
9h ago
Electronics Engineering Manager
CoMind
London, UK
9h ago
Director of Information Technology
Zavation Medical Products
9h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
3 companies competing in this space